Manejo y tratamiento de infección fetal por citomegalovirus
DOI:
https://doi.org/10.23857/dc.v9i2.3564Palabras clave:
citomegalovirus, infección materna, gestación, auditivo, neurológicoResumen
El riesgo de transmisión madre-feto por citomegalovirus depende del momento del embarazo en que ocurre la infección materna. Es mayor mientras más avanzado está el embarazo. La infección congénita por CMV (CMVc) es la infección connatal más prevalente en la actualidad en nuestro medio. Dado que su diagnóstico durante la gestación es difícil y la mayoría de los pacientes nacen asintomáticos, se trata de una infección probablemente infradiagnosticada. A largo plazo, puede producir secuelas principalmente a nivel auditivo y neurológico provocando un deterioro en la calidad de vida de dichos pacientes y sus familias. Es por ello que consideramos necesario protocolizar su manejo y tratamiento para contribuir a mejorar su pronóstico.
Citas
Manicklal S, Emery V C, Lazzarotto T, Boppana S B, Gupta R K. The “silent” global burden of congenital cytomegalovirus. Clin Microbiol Rev. 2013; 26(1): 86-102. doi: 10.1128/CMR.00062-12 [ Links ]
Rawlinson W D, Boppana S B, Fowler K B, Kimberlin D W, Lazzarotto T, Alain S, et al. Congenital cytomegalovirus infection in pregnancy and the neonate: consensus recommendations for prevention, diagnosis, and therapy. Lancet Infect Dis. 2017; 17(6): e177-e88. doi: 10.1016/S1473-3099(17)30143-3. [ Links ]
Leruez-Ville M, Magny J F, Couderc S, Pichon C, Parodi M, Bussieres L, et al. Risk factors for congenital cytomegalovirus infection following primary and nonprimary maternal infection: a prospective neonatal screening study using polymerase chain reaction in saliva. Clin Infect Dis. 2017; 65(3): 398-404. doi: 10.1093/cid/cix337 [ Links
Baquero-Artigao F, Grupo de Estudio de la Infección Congénita por Citomegalovirus de la Sociedad Espanola de Infectologia P. Consensus document from the Spanish Society of Paediatric Infectious Diseases (SEIP) on the diagnosis and treatment of congenital cytomegalovirus infection. An Pediatr (Barc). 2009; 71(6) :535-47. doi: 10.1016/j.anpedi.2009.07.029 [ Links ]
Morton C C, Nance W E. Newborn hearing screening-a silent revolution. N Engl J Med. 2006; 354(20): 2151-64. doi: 10.1056/NEJMra050700 [ Links ]
Foulon I, De Brucker Y, Buyl R, Lichtert E, Verbruggen K, Pierard D, et al. Hearing loss with congenital cytomegalovirus infection. Pediatrics. 2019; 144(2). doi: 10.1542/peds.2018-3095 [ Links
Zuhair M, Smit G S A, Wallis G, Jabbar F, Smith C, Devleesschauwer B, et al. Estimation of the worldwide seroprevalence of cytomegalovirus: A systematic review and meta-analysis. Rev Med Virol. 2019; 29(3): e2034. doi: 10.1002/rmv.2034 [ Links ]
Vial P, Torres J, Stagno S, González F, Donoso E, Alford Ch, et al. Estudio serologico citomegalovirus, virus del herpes simple y de la rubéola, hepatitis B y Toxoplasma gondii en dos poblaciones de gestantes en Santiago, Chile. Bol. Oficina Sanit. Panam; 1985; 99(5): 528-38. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/3006719. [ Links ]
Suárez M Briones H, Alarcón G, Aliaga P, Grunberg A, Diego S, et al. Virus del herpes simple y citomegalovirus en universitarias chilenas embarazadas. Bol Oficina Sanit Panam (OSP). 1991; 111(4). Retrieved from https://iris.paho.org/handle/10665.2/16582. [ Links ]
Yamamoto M P P, Wilhelm J, Bradford R, Lira F, Insunza F, et al. Alta prevalencia de IgG anticitomegalovírus en 583 embarazos: Hospital Padre Hurtado. Rev Chil Obstet Ginecol 2009; 74(2): 102-6. https://scielo.conicyt.cl/pdf/rchog/v74n2/art06.pdf. [ Links ]
Mussi-Pinhata M M, Yamamoto A Y, Aragon D C, Duarte G, Fowler K B, Boppana S, et al. Seroconversion for cytomegalovirus infection during pregnancy and fetal infection in a highly seropositive population: “The BraCHS Study”. J Infect Dis. 2018; 218(8): 1200-4. doi: 10.1093/infdis/jiy321.
Puhakka L, Lappalainen M, Lonnqvist T, Niemensivu R, Lindahl P, Nieminen T, et al. The burden of congenital cytomegalovirus infection: a prospective cohort study of 20 000 infants in Finland. J Pediatric Infect Dis Soc. 2019; 8(3): 205-12. doi: 10.1093/jpids/piy027.
Feldman B, Yinon Y, Tepperberg Oikawa M, Yoeli R, Schiff E, Lipitz S. Pregestational, periconceptional, and gestational primary maternal cytomegalovirus infection: prenatal diagnosis in 508 pregnancies. Am J Obstet Gynecol. 2011; 205(4): 342 e1-6. doi: 10.1016/j.ajog.2011.05.030.
Revello M G, Gerna G. Diagnosis and management of human cytomegalovirus infection in the mother, fetus, and newborn infant. Clin Microbiol Rev. 2002; 15(4): 680-715. doi: 10.1128/CMR.15.4.680-715.2002.
Hadar E, Yogev Y, Melamed N, Chen R, Amir J, Pardo J. Periconceptional cytomegalovirus infection: pregnancy outcome and rate of vertical transmission. Prenat Diagn. 2010; 30(12-13): 1213-6. doi: 10.1002/pd.2654.
Chatzakis C, Ville Y, Makrydimas G, Dinas K, Zavlanos A, Sotiriadis A. Timing of primary maternal cytomegalovirus infection and rates of vertical transmission and fetal consequences. Am J Obstet Gynecol. 2020; 223(6): 870-83 e11. doi: 10.1016/j.ajog.2020.05.038.
Cannon M J, Schmid D S, Hyde T B. Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection. Rev Med Virol. 2010; 20(4): 202-13. doi: 10.1002/rmv.655.
Fowler K B, Stagno S, Pass R F. Maternal immunity and prevention of congenital cytomegalovirus infection. JAMA. 2003; 289(8): 1008-11. doi: 10.1001/jama.289.8.1008.
Kenneson A, Cannon M J. Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev Med Virol. 2007; 17(4): 253-76. doi: 10.1002/rmv.535.
Maltezou P G, Kourlaba G, Kourkouni E, Luck S, Blazquez-Gamero D, Ville Y, et al. Maternal type of CMV infection and sequelae in infants with congenital CMV: Systematic review and meta-analysis. J Clin Virol. 2020; 129: 104518. doi: 10.1016/j.jcv.2020.104518.
Faure-Bardon V, Magny J F, Parodi M, Couderc S, Garcia P, Maillotte A M, et al. Sequelae of congenital cytomegalovirus following maternal primary infections are limited to those acquired in the first trimester of pregnancy. Clin Infect Dis. 2019; 69(9): 1526-32. doi: 10.1093/cid/ciy1128.
Ross S A, Fowler K B, Ashrith G, Stagno S, Britt W J, Pass R F, et al. Hearing loss in children with congenital cytomegalovirus infection born to mothers with preexisting immunity. J Pediatr. 2006; 148(3): 332-6. doi: 10.1016/j.jpeds.2005.09.003.
Townsend C L, Forsgren M, Ahlfors K, Ivarsson S A, Tookey P A, Peckham C S. Long-term outcomes of congenital cytomegalovirus infection in Sweden and the United Kingdom. Clin Infect Dis. 2013; 56(9): 1232-9. doi: 10.1093/cid/cit018.
Lanzieri T M, Dollard S C, Bialek S R, Grosse S D. Systematic review of the birth prevalence of congenital cytomegalovirus infection in developing countries. Int J Infect Dis. 2014; 22: 44-8. doi: 10.1016/j.ijid.2013.12.010.
Estripeaut D, Moreno Y, Ahumada Ruiz S, Martinez A, Racine J D, Saez-Llorens X. Seroprevalence of cytomegalovirus infection in puerperal women and its impact on their newborns. An Pediatr (Barc). 2007; 66(2): 135-9. doi: 10.1157/13098930.
Rico A, Dollard S C, Valencia D, Corchuelo S, Tong V T, Laiton-Donato K, et al. Epidemiology of cytomegalovirus Infection among mothers and infants in Colombia. J Med Virol. 2021; 93(11): 6393-7. doi: 10.1002/jmv.26815.
Luchsinger V, Suarez M, Schultz R, Barraza P, Guzman M, Terrada L, et al. [Incidence of congenital cytomegalovirus infection in newborn infants of different socioeconomic strata]. Rev Med Chil. 1996;124(4):403-8. Epub 1996/04/01. PubMed PMID: 9110478.
Leruez-Ville M, Guilleminot T, Stirnemann J, Salomon LJ, Spaggiari E, Faure-Bardon V, et al. Quantifying the burden of congenital cytomegalovirus infection with long-term sequelae in subsequent pregnancies of women seronegative at their first pregnancy. Clin Infect Dis. 2020; 71(7): 1598-603. doi: 10.1093/cid/ciz1067.
Dollard S C, Grosse S D, Ross D S. New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection. Rev Med Virol. 2007; 17(5): 355-63. doi: 10.1002/rmv.544.
Fowler K B, McCollister F P, Dahle A J, Boppana S, Britt W J, Pass R F. Progressive and fluctuating sensorineural hearing loss in children with asymptomatic congenital cytomegalovirus infection. J Pediatr. 1997; 130(4): 624-30. doi: 10.1016/s0022-3476(97)70248-8.
Pass R F, Stagno S, Myers G J, Alford C A. Outcome of symptomatic congenital cytomegalovirus infection: results of long-term longitudinal follow-up. Pediatrics. 1980; 66(5): 758-62. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/6159568.
Boppana S B, Ross S A, Fowler K B. Congenital cytomegalovirus infection: clinical outcome. Clin Infect Dis. 2013; 57 (Suppl 4): S178-81. doi: 10.1093/cid/cit629.
Estadisticas vitales https://www.ine.cl/estadisticas/sociales/demografia-y-vitales/nacimientos-matrimonios-y-defunciones).
Cheeran M C, Lokensgard J R, Schleiss M R. Neuropathogenesis of congenital cytomegalovirus infection: disease mechanisms and prospects for intervention. Clin Microbiol Rev. 2009; 22(1): 99-126, Table of Contents. doi: 10.1128/CMR.00023-08.
Nigro G, Anceschi M M, Cosmi E V, Congenital Cytomegalic Disease Collaborating G. Clinical manifestations and abnormal laboratory findings in pregnant women with primary cytomegalovirus infection. Br J Obstet Gyneol. 2003; 110(6): 572-7. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/12798474.
Torii Y, Yoshida S, Yanase Y, Mitsui T, Horiba K, Okumura T, et al. Serological screening of immunoglobulin M and immunoglobulin G during pregnancy for predicting congenital cytomegalovirus infection. BMC Pregnancy Childbirth. 2019; 19(1): 205. doi: 10.1186/s12884-019-2360-1.
Juhl D, Vockel A, Luhm J, Ziemann M, Hennig H, Gorg S. Comparison of the two fully automated anti-HCMV IgG assays: Abbott Architect CMV IgG assay and Biotest anti-HCMV recombinant IgG ELISA. Transfus Med. 2013; 23(3): 187-94. doi: 10.1111/tme.12036.
Revello M G, Vauloup-Fellous C, Grangeot-Keros L, van Helden J, Dickstein Y, Lipkin I, et al. Clinical evaluation of new automated cytomegalovirus IgM and IgG assays for the Elecsys((R)) analyser platform. Eur J Clin Microbiol Infect Dis. 2012; 31(12): 3331-9. doi: 10.1007/s10096-012-1700-0.
Sellier Y, Guilleminot T, Ville Y, Leruez-Ville M. Comparison of the LIAISON((R)) CMV IgG Avidity II and the VIDAS((R)) CMV IgG Avidity II assays for the diagnosis of primary infection in pregnant women. J Clin Virol. 2015; 72: 46-8. doi: 10.1016/j.jcv.2015.08.018.
Leruez-Ville M, Foulon I, Pass R, Ville Y. Cytomegalovirus infection during pregnancy: state of the science. Am J Obstet Gynecol. 2020; 223(3): 330-49. doi: 10.1016/j.ajog.2020.02.
Leruez-Ville M, Sellier Y, Salomon L J, Stirnemann J J, Jacquemard F, Ville Y. Prediction of fetal infection in cases with cytomegalovirus immunoglobulin M in the first trimester of pregnancy: a retrospective cohort. Clin Infect Dis. 2013; 56(10): 1428-35. doi: 10.1093/cid/cit059.
Revello M G, Zavattoni M, Sarasini A, Percivalle E, Simoncini L, Gerna G. Human cytomegalovirus in blood of immunocompetent persons during primary infection: prognostic implications for pregnancy. J Infect Dis. 1998; 177(5): 1170-5. doi: 10.1086/515277.
Garrigue I, Doussau A, Asselineau J, Bricout H, Couzi L, Rio C, et al. Prediction of cytomegalovirus (CMV) plasma load from evaluation of CMV whole-blood load in samples from renal transplant recipients. J Clin Microbiol. 2008; 46(2): 493-8. doi: 10.1128/JCM.01499-07.
Cofré F, Delpiano L, Labrana Y, Reyes A, Sandoval A, Izquierdo G. TORCH syndrome: Rational approach of pre and post natal diagnosis and treatment. Recommendations of the Advisory Committee on Neonatal Infections Sociedad Chilena de Infectologia, 2016. Rev Chilena Infectol. 2016; 33(2): 191-216. doi: 10.4067/S0716-10182016000200010.
Penner J, Hernstadt H, Burns J E, Randell P, Lyall H. Stop, think SCORTCH: rethinking the traditional ‘TORCH’ screen in an era of re-emerging syphilis. Arch Dis Child. 2021; 106(2): 117-24. doi: 10.1136/archdischild-2020-318841.
Descargas
Publicado
Cómo citar
Número
Sección
Licencia
Derechos de autor 2023 Líder Leonardo Mero Mero, Aarón David Montero Altamirano, Jonathan Steven Álvarez Silva, Jasmín Alexandra Toledo Asanza
Esta obra está bajo una licencia internacional Creative Commons Atribución 4.0.
Authors retain copyright and guarantee the Journal the right to be the first publication of the work. These are covered by a Creative Commons (CC BY-NC-ND 4.0) license that allows others to share the work with an acknowledgment of the work authorship and the initial publication in this journal.
